{
    "clinical_study": {
        "@rank": "112509", 
        "acronym": "3G", 
        "arm_group": [
            {
                "arm_group_label": "Refined grain", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Refined grain diet: Participants consume less than 10 g of whole grain per day (corresponds to the whole grain intake below the 10th percentile of the population)"
            }, 
            {
                "arm_group_label": "Whole grain", 
                "arm_group_type": "Active Comparator", 
                "description": "Whole grain diet: Participants consume more than 75g of whole grain  per day (corresponds to the whole grain intake of the 90th percentile of the population)"
            }
        ], 
        "brief_summary": {
            "textblock": "Objective: To identify how specific changes of the whole grain content in the diet affect\n      the host-gut microbiome interactions with implications for metabolic health .\n\n      Design: A randomized, controlled, single-blinded, cross-over intervention trial consisting\n      of two 8-week intervention periods, separated by a 6-week wash-out period. A total of 60\n      participants will be included.\n\n      Intervention: low vs. high whole grain intake."
        }, 
        "brief_title": "The Effect of Whole Grain on Gut Microbiome and Metabolic Health", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Metabolic Disease", 
            "Injury of Gastrointestinal Tract"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Metabolic Diseases", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study is designed as a randomized, controlled, single-blinded, cross-over intervention\n      trial consisting of two 8-week interventions periods, separated by a 6-week wash-out period.\n      A total number of 60 participants will be included. Participants consume, in randomized\n      order, a diet rich in whole grain in the active treatment period and a refined grain diet\n      during the control period.\n\n      Measurements: Insulin sensitivity will be assessed by means of a meal challenge test and by\n      the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) which is the primary\n      outcome of this study. Secondary outcomes include metabolic and inflammatory markers,\n      appetite hormones, transit time, and GM composition. Furthermore, selected control measures\n      are included; 4-day food records and a study intervention diary."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Body mass index (BMI): 25 - 35 kg/m2\n\n          -  No medical prescribed diet\n\n          -  Weight stable\n\n          -  No blood donation during the study\n\n          -  Intense sporting activities less than 10h/ week\n\n          -  Alcohol consumption less than 14 units/ week (female) and 21 units/ week (male)\n\n          -  Signed written consent\n\n        Exclusion Criteria:\n\n          -  Pharmacological treatment; hypertension, diabetes and blood lipid regulation\n\n          -  Lactating (or lactating, 6 weeks ago), pregnant (or pregnant, 3 months ago) or wish\n             to become pregnant during the study\n\n          -  Participation in another biomedical trial 1 month prior to study start\n\n          -  Diagnosed with any form of diabetes, celiac disease or chronic pancreatitis\n\n          -  Reported chronic gastrointestinal disorders\n\n          -  Antibiotic treatment for 3 month prior to study start\n\n          -  Intake of vitamin, mineral, or pre- or probiotic supplements for 1 month prior to\n             study start\n\n          -  Blood hemoglobin < 7.0 mmol/l\n\n          -  Blood donation within 1 month prior to study start"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01731366", 
            "org_study_id": "M206"
        }, 
        "intervention": [
            {
                "arm_group_label": "Whole grain", 
                "description": "Whole grain diet: Participants consume more than 75g of whole grain per day (corresponds to the whole grain intake of the 90th percentile of the population)", 
                "intervention_name": "Whole grain", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Refined grain", 
                "description": "Refined grain diet: Participants consume less than 10 g of whole grain per day (corresponds to the whole grain intake below the 10th percentile of the population)", 
                "intervention_name": "Refined grain", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 16, 2013", 
        "link": {
            "url": "http://www.3g-center.dk/"
        }, 
        "location": {
            "contact": {
                "email": "ll@life.ku.dk", 
                "last_name": "Lotte Lauritzen, Associate professor", 
                "phone": "+45 35332508"
            }, 
            "facility": {
                "address": {
                    "city": "Fredriksberg", 
                    "country": "Denmark", 
                    "zip": "1958"
                }, 
                "name": "Department of Human Nutrition, University of Copenhagen"
            }, 
            "investigator": {
                "last_name": "Lotte Lauritzen, Associate professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Gut, Grain and Greens (3G): The Effect of Wholegrain on Gut Microbiome and Metabolic Health", 
        "other_outcome": [
            {
                "description": "Assessment of dietary intake via food frequency questionnaire as a measure of compliance", 
                "measure": "4-days precoded food diary", 
                "safety_issue": "No", 
                "time_frame": "December 2014"
            }, 
            {
                "description": "Assessed as DHA percentage in a whole blood fatty acid analysis. Included as a potential effect modificator in relation to immune function and metabolic outcomes.", 
                "measure": "n-3 fatty acid status", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Measured in plasma as a marker of compliance to the whole grain intervention.", 
                "measure": "Alkyresorcinol", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }
        ], 
        "overall_official": {
            "affiliation": "University of Copenhagen", 
            "last_name": "Lotte Lauritzen, Associate professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Homeostasis Model Assessment of fasting Insulin Resistance (HOMA-IR: glucose (mmol/l( x insulin (pmol/l)/22.5)", 
                "measure": "HOMA-IR", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Altered quantitative metagenomics at bacterial gene- and species levels, which is a non-specific outcome, but included as the main hypothesis of the project is to test if HOMA-IR is affected via changes in the gut microbiome.", 
                "measure": "Metagenomic profile", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01731366"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "AAstrup", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Participants are instructed in swallowing capsules containing different small non-invasive and non-absorbable plastic pellets for 6 consecutive days. On the seventh day they are having an X-ray of the abdomen taken.", 
                "measure": "Mean intestinal transit time", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "5 hours urine collection following intake of lactulose and mannitol", 
                "measure": "Gastrointestinal permeability, Lactulose/ mannitol ratio", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Measurement of breath hydrogen excretion (at before and 30, 60, 90, 120, 150, 180 after intake of standard breakfast) and plasma short-chain fatty acids (fasting and 30, 60, 120, 180 minutes after standard breakfast)", 
                "measure": "Colonic fermentation", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Determination of fasting microbial composition of flora.", 
                "measure": "Saliva microbial flora", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Measurement of supine systolic and diastolic blood pressure (3 times)", 
                "measure": "Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Determination of different appetite hormones in fasting and postprandial blood samples (30, 60, 120, 180 minutes after standard breakfast)", 
                "measure": "Appetite hormones", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Measurement of different blood lipids in fasting and postprandial blood samples (30, 60, 120, 180 minutes after standard breakfast)", 
                "measure": "Blood lipid profile", 
                "safety_issue": "No", 
                "time_frame": "At the end of the interventions periods"
            }, 
            {
                "description": "Measurement of body fat mass and percentage via bio-impedance", 
                "measure": "Body composition", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Assessment of subjective appetite sensation via visual analogue scales", 
                "measure": "Subjective appetite sensation", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Assessment of energy intake at an ad libitum meal 3 hours after a standard breakfast", 
                "measure": "Energy intake", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Production of cytokines (such as IL-1beta, IL-6) in stimulated whole blood cultures.", 
                "measure": "Ex vivo cytokine production", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Assessed by mRNA qPCR in whole blood and cells from whole blood stimulation. Main focus is put on genes involved in immune function and metabolic regulation.", 
                "measure": "Gene expression", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Assessed by flow cytometry of whole blood.", 
                "measure": "Immune cell profiling", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Fasting plasma cytokines, hsCRP, and LPS/LPS-BP", 
                "measure": "Immune markers", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Assessed by hematological cell counts", 
                "measure": "Blood immune cell content", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Measurement of plasma concentrations of Insulin, Proinsulin and HbA1c", 
                "measure": "Markers og glucose hemostasis", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Assessed by plasma homocystein, SAM/SAH and betain", 
                "measure": "Markers of one-carbon metabolism", 
                "safety_issue": "No", 
                "time_frame": "At the end of the intervention periods"
            }, 
            {
                "description": "Leptin and adiponectin", 
                "measure": "Plasma adipokines", 
                "safety_issue": "No", 
                "time_frame": "December 2015"
            }
        ], 
        "source": "University of Copenhagen", 
        "sponsors": {
            "collaborator": {
                "agency": "Technical University of Denmark", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}